Skip to main content
. Author manuscript; available in PMC: 2010 Feb 10.
Published in final edited form as: Am J Physiol Endocrinol Metab. 2003 Apr 8;285(2):E311. doi: 10.1152/ajpendo.00490.2002

Table 2.

Hyperinsulinemic euglycemic clamp

Baseline
Stage 1
Stage 2
CON EST CON EST CON EST
Estradiol, pg/ml 11±7 11±7 10±5 217±79* 10±4 171±59*
Estrone, pg/ml 16±7 16±7 12±6 263±114* 11±4 195±94*
Glucose, mg/dl 90±9 91±8 88±3 90±4 90±6 90±5
Insulin, μU/ml 7±3 7±3 16±4 15±4 78±16 63±12*
Epi, pg/ml 28±11 26±8 33±16 34±17 34±20 35±16
NE, pg/ml 195±83 217±73 222±70 252±70 238±90 232±61
FFA, μeq/l 765±214 717±133 210±109 192±100 116±28 116±33
Glycerol, μmol/l 81±20 74±15 41±16 40±16 34±11 30±7

Values are means ± SD. EST, estrogen day; CON, control day; Epi, epinephrine; NE, norepinephrine; FFA, free fatty acids.

*

P < 0.01 vs. CON day.

HHS Vulnerability Disclosure